InoRx published a 2,000-participant medical device study that wasn't a speed problem at all.
Published
Signal category
Research & Knowledge
Quote
“A 2,000-participant medical device study that wasn't a speed problem at all.”
— Christopher Macri|InoRx team
Company
InoRx
Contract Research Organization accelerating Phase I–IV biotech & pharma trials through India's integrated site network.
- Industry
- Research Services
- Company size
- 22 employees
InoRx is a next-generation Contract Research Organization (CRO) built to accelerate clinical development through innovation, patient access, and operational excellence. Headquartered in the U.S. with operations in India, InoRx leverages its affiliate network of academic medical centers and clinics, high quality standards, and experienced clinical operations, to deliver faster, more cost effective, highly reliable clinical studies for sponsors worldwide. Backed by SRM Group InoRx is part of the SRM Group, a diversified global enterprise with $1.4 billion in revenue and thousands of employees across healthcare, education, technology, and more. SRM’s decades of experience and reputation in medical research, hospital systems, and academic excellence provide InoRx with scientific expertise, infrastructure, and access to a vast network of clinicians, research sites, and patients.